Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Hansoh Pharmaceutical Group Company Limited ( (HK:3692) ) has shared an announcement.
Hansoh Pharmaceutical Group Company Limited has announced a change in its principal place of business in Hong Kong, effective January 10, 2025. This relocation to a new address in Causeway Bay signifies a strategic move to potentially enhance operational efficiency and strengthen its market presence in Hong Kong.
More about Hansoh Pharmaceutical Group Company Limited
Hansoh Pharmaceutical Group Company Limited is a pharmaceutical company incorporated in the Cayman Islands, primarily engaged in the development, production, and sale of pharmaceutical products. It focuses on providing healthcare solutions and is listed on the Hong Kong Stock Exchange.
YTD Price Performance: -6.13%
Average Trading Volume: 7,824,382
Technical Sentiment Consensus Rating: Buy
Current Market Cap: HK$96.28B
For an in-depth examination of 3692 stock, go to TipRanks’ Stock Analysis page.
